GO:0015884 folic acid transport: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0015884 folic acid transport describes the directed movement of folic acid (pteroylglutamic acid) into, out of, or within a cell, or between cells, via transporters or pores.
• Folic acid is a vitamin B9 compound essential for purine and pyrimidine synthesis, making its transport critical for nucleotide metabolism and cell proliferation.
• Multiple transport systems exist, including high-affinity carrier-mediated systems and folate-binding protein-dependent pathways.
• Transport can be sodium-dependent in some tissues, as shown in small intestine studies.
• Folic acid transport is relevant to drug delivery, cancer chemotherapy (e.g., methotrexate), and intestinal absorption.
• Research tools include CRISPR knockout models, transport assays, and structural biology approaches.
Description
Folic acid transport (GO:0015884) is a biological process that mediates the directed movement of folic acid (pteroylglutamic acid) across cellular membranes or within cells, utilizing transporters or pores. Folic acid, also known as vitamin B9, is a water-soluble vitamin essential for one-carbon metabolism and the synthesis of purines and pyrimidines. Because mammals cannot synthesize folate de novo, efficient transport systems are required to absorb dietary folate and distribute it to tissues. This process is fundamental for cell division, DNA synthesis, and amino acid metabolism, and its dysfunction is linked to various pathological conditions. Understanding folic acid transport is therefore critical for researchers in nutrition, cancer biology, and pharmacology. The transport mechanisms involve multiple protein families, including the reduced folate carrier (RFC), folate receptors, and organic anion transporters. These systems exhibit tissue-specific expression and regulation, ensuring adequate folate supply under varying physiological conditions. This article provides a comprehensive overview of the ontology, molecular mechanisms, key genes, and research methodologies associated with folic acid transport, based on authoritative QuickGO data and verified PubMed literature.
folic acid transport At A Glance
| GO ID | GO:0015884 |
|---|---|
| GO term | folic acid transport |
| Ontology | biological_process |
| Synonym | folate transport, vitamin B9 transport, vitamin M transport |
| Definition | The directed movement of folic acid (pteroylglutamic acid) into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. |
| Major function | Uptake and distribution of folate for nucleotide synthesis and one-carbon metabolism |
| Related transporters | Reduced folate carrier (RFC/SLC19A1), folate receptors (FOLR1, FOLR2), organic anion transporters (OAT-K1) |
| Tissue distribution | Intestine, kidney, liver, retina, placenta, and other tissues |
| Disease relevance | Cancer, neural tube defects, anemia, and methotrexate resistance |
What Is GO:0015884?
According to the Gene Ontology, folic acid transport (GO:0015884) is defined as the directed movement of folic acid (pteroylglutamic acid) into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. Folic acid is widely distributed as a member of the vitamin B complex and is essential for the synthesis of purines and pyrimidines. This process encompasses the translocation of folate across biological membranes, which can occur via carrier-mediated transport, receptor-mediated endocytosis, or channel-mediated diffusion.
Why Is folic acid transport Important in Cell Biology?
Folic acid transport is essential for maintaining cellular folate homeostasis, which is required for DNA synthesis, repair, and methylation. Defects in transport can lead to folate deficiency, megaloblastic anemia, and increased risk of neural tube defects. Moreover, folate transporters are targets for antifolate drugs like methotrexate, and their expression levels influence drug efficacy and resistance in cancer therapy. Understanding the mechanisms of folic acid transport is therefore crucial for developing nutritional interventions and chemotherapeutic strategies.
• Folic acid transport is required for intestinal absorption of dietary folate.
• It supplies folate to rapidly dividing cells, supporting nucleotide biosynthesis.
• Transporters mediate the uptake of antifolate drugs, affecting chemotherapy outcomes.
• Folate-binding proteins modulate transport efficiency and folate bioavailability.
• Defective transport is associated with neural tube defects and cardiovascular diseases.
• Transport systems are regulated by developmental and physiological signals.
• Folic acid transport is a determinant of methotrexate sensitivity in cancer cells.
• Studying transport mechanisms aids in designing targeted drug delivery systems.
• Genetic variations in transporters can affect folate status and disease risk.
• Model systems like Caco-2 cells and organ cultures are used to study transport.
What Happens During folic acid transport?
Recognition and Binding of Folic Acid
In simple terms: The first step is when a transporter protein on the cell membrane recognizes and grabs onto folic acid.
Folic acid transport begins with the specific recognition of folate by membrane-associated proteins. Structural studies have revealed that mammalian folate transporters, such as the reduced folate carrier (RFC), possess a binding pocket that accommodates the pteroylglutamate moiety. Folate-binding proteins (FBPs) can also sequester folate and facilitate its delivery to cells. In human retinoblastoma cells, a high-affinity carrier-mediated system mediates folic acid uptake, indicating the presence of specific binding sites. Similarly, in intestinal mucosa, distinct carriers recognize folic acid and its derivatives.
Translocation Across the Membrane
In simple terms: After binding, the transporter undergoes a shape change to move folic acid across the cell membrane into the cell.
Following binding, the transporter undergoes conformational changes to translocate folic acid across the lipid bilayer. The reduced folate carrier (RFC) operates via an alternating access mechanism, as elucidated by structural and biochemical studies. In the small intestine, folic acid transport is sodium-dependent, suggesting a secondary active transport mechanism. Additionally, organic anion transporters such as OAT-K1 in the kidney can transport folic acid derivatives, and trans-stimulation effects have been observed with methotrexate.
Intracellular Release and Metabolism
In simple terms: Once inside, folic acid is released from the transporter and can be used by the cell or converted into other forms.
Upon entering the cytoplasm, folic acid is released from the transporter and becomes available for metabolic processes. It is typically reduced to dihydrofolate and tetrahydrofolate, which serve as cofactors in one-carbon transfer reactions. In Caco-2 cell models, folate-binding protein enhances the transport of both folic acid and 5-methyltetrahydrofolate, indicating that intracellular release and subsequent metabolism are influenced by binding proteins. The transported folate can also be effluxed out of cells by specific transporters, contributing to folate homeostasis.
Regulation of Transport Activity
In simple terms: The cell can adjust how much folic acid it takes up by changing the number or activity of transporters.
Folic acid transport is regulated at multiple levels, including transcriptional control of transporter genes and post-translational modifications. For instance, the expression of RFC and folate receptors is modulated by folate status and cellular demands. In organ-cultured human intestinal mucosa, transport activity adapts to folate concentrations, suggesting feedback regulation. Hormonal and developmental signals also influence transport capacity, as seen in retinoblastoma cells where high-affinity transport is maintained.
Key Genes Involved in GO:0015884 folic acid transport
The following genes encode proteins that directly mediate or regulate folic acid transport, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC19A1 | Reduced folate carrier (RFC); major transporter for reduced folates and methotrexate | Target for antifolate drugs; mutations affect transport kinetics |
| FOLR1 | Folate receptor alpha; mediates folate uptake via endocytosis | Overexpressed in cancers; target for folate-conjugated drugs |
| FOLR2 | Folate receptor beta; expressed in placenta and hematopoietic cells | Role in fetal development and immune regulation |
| SLC46A1 | Proton-coupled folate transporter (PCFT); intestinal folate absorption | Mutations cause hereditary folate malabsorption |
| SLC19A2 | Thiamine transporter; can also transport folate | Associated with thiamine-responsive megaloblastic anemia |
| SLC19A3 | Thiamine transporter; potential folate transport | Mutations linked to biotin-responsive basal ganglia disease |
| ABCC1 | Multidrug resistance protein; efflux of folate derivatives | Contributes to antifolate resistance |
| ABCC2 | Multidrug resistance protein; efflux of folate | Role in drug disposition |
| ABCC3 | Multidrug resistance protein; efflux of folate | Potential impact on folate homeostasis |
| OAT-K1 | Organic anion transporter; renal folate transport | Trans-stimulation by folic acid derivatives |
| GCPII | Glutamate carboxypeptidase II; releases folate from dietary polyglutamates | Target for prostate cancer imaging and therapy |
| FOLH1 | Prostate-specific membrane antigen; folate hydrolase | Biomarker in prostate cancer |
| SLC25A32 | Mitochondrial folate transporter | Defects cause exercise intolerance and neural tube defects |
| MTHFR | Methylenetetrahydrofolate reductase; folate metabolism | Polymorphisms affect folate status and disease risk |
| MTR | Methionine synthase; uses folate as cofactor | Linked to hyperhomocysteinemia |
| MTHFD1 | Methylenetetrahydrofolate dehydrogenase; folate metabolism | Genetic variants affect folate-related pathways |
| SHMT1 | Serine hydroxymethyltransferase; folate metabolism | Role in one-carbon metabolism |
| TYMS | Thymidylate synthase; uses folate cofactor | Target of 5-fluorouracil |
How Is folic acid transport Regulated?
Folic acid transport is regulated by a combination of transcriptional, post-transcriptional, and post-translational mechanisms. The expression of folate transporters such as RFC and folate receptors is influenced by intracellular folate levels, with depletion often leading to upregulation of transport activity. In intestinal mucosa, transport adapts to dietary folate, suggesting a feedback regulatory loop. Hormones and growth factors can also modulate transport; for example, in retinoblastoma cells, high-affinity transport is maintained under specific culture conditions. Additionally, the sodium dependence of intestinal folic acid transport implies regulation by ion gradients and cellular energy status. Folate-binding proteins in milk and serum can either enhance or inhibit transport depending on context. Overall, regulation ensures adequate folate supply for cellular metabolism while preventing toxicity.
folic acid transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC19A1 | Methotrexate resistance in cancer | Knockout in cancer cell lines followed by drug sensitivity assays |
| FOLR1 | Ovarian cancer; target for folate-conjugated therapeutics | Overexpression in HEK293 cells for uptake studies |
| SLC46A1 | Hereditary folate malabsorption | Knockout mice or patient-derived organoids |
| MTHFR | Neural tube defects; cardiovascular disease | Point mutation knock-in in mice |
| OAT-K1 | Renal folate wasting | Knockout in renal epithelial cells |
Folic Acid Transport in Cancer
Altered folate transport is a hallmark of many cancers. Overexpression of folate receptor alpha (FOLR1) is observed in ovarian, lung, and breast cancers, where it facilitates increased folate uptake to support rapid proliferation. The reduced folate carrier (SLC19A1) is also frequently upregulated, and its activity influences sensitivity to antifolate drugs like methotrexate. In retinoblastoma cells, a high-affinity carrier-mediated system for folic acid has been characterized, highlighting the importance of transport in tumor growth. Targeting folate transporters is a promising strategy for cancer therapy, including folate-conjugated drugs and antifolate agents.
Folic Acid Transport and Neural Tube Defects
Impaired folate transport across the placenta and blood-brain barrier is associated with neural tube defects (NTDs). Mutations in the proton-coupled folate transporter (PCFT/SLC46A1) cause hereditary folate malabsorption, which can lead to NTDs if untreated. Additionally, polymorphisms in genes involved in folate metabolism, such as MTHFR, interact with transport efficiency to influence NTD risk. Adequate maternal folate status, dependent on intestinal absorption and transport, is critical for fetal development.
Folic Acid Transport in Intestinal and Renal Disorders
Defects in intestinal folic acid transport can result in megaloblastic anemia due to impaired absorption. Studies using organ-cultured human intestinal mucosa have demonstrated distinct carriers for folic acid, and sodium dependence is essential for optimal transport. In the kidney, organic anion transporters such as OAT-K1 mediate folate reabsorption, and their dysfunction may contribute to folate wasting. Folate-binding proteins in the gut can modulate transport efficiency, as shown in Caco-2 cell models.
From folic acid transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does SLC19A1 mediate folic acid transport? | CRISPR knockout in HeLa or Caco-2 cells |
| What is the effect of a specific point mutation in SLC46A1 on transport? | Point mutation knock-in in HEK293 cells |
| Can FOLR1 overexpression increase folate uptake? | Overexpression in CHO cells |
| How does tagged RFC localize in cells? | Tagged knock-in of SLC19A1 with GFP |
| What is the role of OAT-K1 in renal folate reabsorption? | Knockout in mouse kidney epithelial cells |
| Does folate-binding protein enhance transport? | Co-culture of Caco-2 cells with FBP |
How to Study the folic acid transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radiolabeled folate uptake | Transport activity | Kinetic analysis in cell lines |
| Cryo-EM | Protein structure | Mechanistic studies of RFC |
| RNA-seq | Gene expression | Identifying transporters in tissues |
| CRISPR knockout | Gene function | Validating transporter genes |
| Caco-2 monolayer assay | Intestinal transport | Studying folate absorption |
| Organ culture | Tissue-level transport | Human intestinal mucosa studies |
| Sodium dependence assay | Ion requirement | Characterizing transport mechanisms |
Transport Assays
Radiolabeled or fluorescent folate analogs are used to measure uptake and efflux in cell lines. For example, [3H]folic acid uptake assays in retinoblastoma cells revealed a high-affinity carrier-mediated system. Similarly, Caco-2 cell monolayers are employed to study intestinal transport and the effect of folate-binding proteins. These assays are quantitative and can be adapted for high-throughput screening.
Structural Biology
X-ray crystallography and cryo-electron microscopy have provided insights into the structure of mammalian folate transporters, such as the reduced folate carrier. These techniques reveal substrate binding sites and conformational changes during transport, guiding mutagenesis studies.
Gene Expression Analysis
Quantitative RT-PCR and RNA-seq are used to measure expression levels of folate transporters under different conditions. For instance, expression of SLC19A1 and FOLR1 is often correlated with folate status and drug sensitivity. This helps identify regulatory mechanisms.
CRISPR-Based Functional Genomics
CRISPR knockout screens can identify genes essential for folic acid transport. By knocking out candidate transporters and measuring folate uptake or cell viability in folate-deficient media, researchers can pinpoint critical genes. This approach is scalable and unbiased.
How CRISPR Can Be Used to Study GO:0015884 folic acid transport
Knockout
CRISPR knockout of candidate folate transporter genes (e.g., SLC19A1, FOLR1) in cell lines such as HeLa or Caco-2 can abolish or reduce folic acid transport, confirming their role. This approach is used to study the contribution of individual transporters to overall folate uptake.
Point Mutation
Introducing specific point mutations identified in patients (e.g., in SLC46A1) via CRISPR knock-in allows functional characterization of transport defects. This helps establish causality between genetic variants and impaired folate transport.
Knock-in
Tagged knock-in of transporters (e.g., GFP-SLC19A1) enables live-cell imaging and localization studies. This provides insights into trafficking and membrane dynamics of folate transporters.
Overexpression
CRISPR activation or cDNA overexpression of folate transporters can increase folate uptake, useful for studying transport kinetics and drug sensitivity. For example, overexpression of FOLR1 in cancer cells enhances folate-conjugated drug uptake.
How EDITGENE Supports folic acid transport Research
Researchers studying folic acid transport-related genes often need to determine whether a candidate gene is causally involved in folate uptake, metabolism, or disease. EDITGENE provides comprehensive CRISPR-based services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for folic acid transport research.
Frequently Asked Questions About folic acid transport
What is folic acid transport?
Folic acid transport (GO:0015884) is the directed movement of folic acid across cell membranes via transporters or pores, essential for nucleotide synthesis and one-carbon metabolism.
What genes are involved in folic acid transport?
Key genes include SLC19A1 (RFC), FOLR1, FOLR2, SLC46A1 (PCFT), and OAT-K1, among others.
How is folic acid transported into cells?
Folic acid is transported by carrier-mediated systems, receptor-mediated endocytosis, or channels, often sodium-dependent in intestine.
What is the role of folate-binding protein in transport?
Folate-binding proteins can enhance or modulate folate transport across cell membranes, as shown in Caco-2 cells.
Is folic acid transport sodium-dependent?
In the small intestine, folic acid transport is sodium-dependent, indicating a secondary active transport mechanism.
How does folic acid transport relate to cancer?
Overexpression of folate transporters supports tumor growth and influences sensitivity to antifolate drugs like methotrexate.
What diseases are linked to defective folic acid transport?
Hereditary folate malabsorption, neural tube defects, and megaloblastic anemia are associated with impaired transport.
What methods study folic acid transport?
Radiolabeled uptake assays, structural biology (cryo-EM), CRISPR screens, and RNA-seq are commonly used.
Can CRISPR be used to study folic acid transport?
Yes, CRISPR knockout, knock-in, and overexpression models help validate transporter function and disease variants.
What is the GO term for folic acid transport?
The Gene Ontology term is GO:0015884, defined as the directed movement of folic acid into, out of, or within a cell.
Conclusion
Folic acid transport (GO:0015884) is a fundamental biological process that ensures cellular uptake and distribution of vitamin B9, critical for nucleotide synthesis and one-carbon metabolism. Dysregulation of this process is implicated in cancer, neural tube defects, and intestinal disorders. Advances in structural biology and CRISPR-based models continue to unravel the molecular details of folate transporters, offering new avenues for therapeutic intervention. Researchers can leverage EDITGENE's services to create custom cell models and accelerate discoveries in folate transport biology.
References
- 1. Newstead S. 2022. Structural basis for recognition and transport of folic acid in mammalian cells.. Curr Opin Struct Biol 74:102353 PMID: 35303537
- 2. Henderson GB. 1990. Folate-binding proteins.. Annu Rev Nutr 10:319-35 PMID: 2166548
- 3. Kansara V et al.. 2008. Folic acid transport via high affinity carrier-mediated system in human retinoblastoma cells.. Int J Pharm 355(1-2):210-9 PMID: 18207340
- 4. Zimmerman J. 1990. Folic acid transport in organ-cultured mucosa of human intestine. Evidence for distinct carriers.. Gastroenterology 99(4):964-72 PMID: 2394350
- 5. Davis RE. 1986. Clinical chemistry of folic acid.. Adv Clin Chem 25:233-94 PMID: 3087140
- 6. Takeuchi A et al.. 2000. Trans-stimulation effects of folic acid derivatives on methotrexate transport by rat renal organic anion transporter, OAT-K1.. J Pharmacol Exp Ther 293(3):1034-9 PMID: 10869408
- 7. Verwei M et al.. 2005. Effect of folate-binding protein on intestinal transport of folic acid and 5-methyltetrahydrofolate across Caco-2 cells.. Eur J Nutr 44(4):242-9 PMID: 15316828
- 8. Zimmerman J et al.. 1986. Role of sodium ion in transport of folic acid in the small intestine.. Am J Physiol 251(2 Pt 1):G218-22 PMID: 2426969
